Application no. and date | 16918763.0 (espacenet) (Federated) (European Patent Register), 20161212 | Patent/reg. no. and date | DK/EP 3524601, 20211013 | Publication date | 20190814 | Priority no. and date | RU 2016139641, 20161010 | EP pub. no. and date |
EP 3524601 20190814 | Effective date | | Applicant/owner | R-Pharm Joint Stock Company (R-Pharm, JSC), Berzarina str. 19 bld. 1
Moscow 123154, RU, Repik, Alexey Evgenievich, 54 Kotoroslnaya nab., Apt. 9
Yaroslavl, 150000, RU | Applicant ref. no. | P78199DK01 | Inventor | IGNATIEV, Vasily Gennadievich, Skolkovskoye Shosse 13 Apt. 212
Moscow 121353, RU, IVACHTCHENKO, Alexandre Vasilievich, E. Hallandale Bch Blvd 1835 442
Hallandale Beach Florida 33009, US, CHAFEEV, Mikhail Airatovich, Gogolia Str. 9 Apt. 73
Moscow region Khimki 141401, RU, REPIK, Alexey Evgenievich, 54 Kotoroslnaya nab., Apt. 9,
Yaroslavl, 150000, RU | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | Title | N-{3-[3-CYCLOPROPYL-5-(2-FLUOR-4-IODPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDIN-1-YL]-PHENYL}-CYCLOPROPANCARBOXAMID-DIMETHYL-SULPHOXIDSOLVAT SOM EN MEK1/2-INHIBITOR | Int. application no. | RU2016000862 | Int. publication no. | WO2018070900 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|